The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery
Open accessAbstract
Animal poisons and venoms are comprised of different classes of molecules displaying wide-ranging pharmacological activities. This review aims to provide an in-depth view of toxin-based compounds from terrestrial and marine organisms used as diagnostic tools, experimental molecules to validate postulated therapeutic targets, drug libraries, prototypes for the design of drugs, cosmeceuticals, and therapeutic agents. However, making these molecules applicable requires extensive preclinical trials, with some applications also demanding clinical trials, in order to validate their molecular target, mechanism of action, effective dose, potential adverse effects, as well as other fundamental parameters. Here we go through the pitfalls for a toxin-based potential therapeutic drug to become eligible for clinical trials and marketing. The manuscript also presents an overview of the current picture for several molecules from different animal venoms and poisons (such as those from amphibians, cone snails, hymenopterans, scorpions, sea anemones, snakes, spiders, tetraodontiformes, bats, and shrews) that have been used in clinical trials. Advances and perspectives on the therapeutic potential of molecules from other underexploited animals, such as caterpillars and ticks, are also reported. The challenges faced during the lengthy and costly preclinical and clinical studies and how to overcome these hindrances are also discussed for that drug candidates going to the bedside. It covers most of the drugs developed using toxins, the molecules that have failed and those that are currently in clinical trials. The article presents a detailed overview of toxins that have been used as therapeutic agents, including their discovery, formulation, dosage, indications, main adverse effects, and pregnancy and breastfeeding prescription warnings. Toxins in diagnosis, as well as cosmeceuticals and atypical therapies (bee venom and leech therapies) are also reported. The level of cumulative and detailed information provided in this review may help pharmacists, physicians, biotechnologists, pharmacologists, and scientists interested in toxinology, drug discovery, and development of toxin-based products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
WITHDRAWN—a resource for withdrawn and discontinued drugs
Siramshetty, V. B., Nickel, J., Omieczynski, C., Gohlke, B.-O., Drwal, M. N., & Preissner, R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1192 · Cited by 286
RetractedDiagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000
Weber, M. A., Schiffrin, E. L., White, W. B., Mann, S., Lindholm, L. H., Kenerson, J. G., Flack, J. M., Carter, B. L., Materson, B. J., Ram, C. V. S., et al. (2014) · The Journal of Clinical Hypertension · doi:10.1111/jch.12237 · Cited by 986
Cushman, D. W., Cheung, H. S., Sabo, E. F., & Ondetti, M. A. (1977) · Biochemistry · doi:10.1021/bi00644a014 · Cited by 892
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K. M., Pennington, M. W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605136103 · Cited by 538
Topol, E. J., Byzova, T. V., & Plow, E. F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11086-3 · Cited by 528
Venoms as a platform for human drugs: translating toxins into therapeutics
King, G. F. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.621940 · Cited by 516
Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom
Ferreira, S. H., Bartelt, D. C., & Greene, L. J. (1970) · Biochemistry · doi:10.1021/bi00815a005 · Cited by 513
A BRADYKININ‐POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARACA
FERREIRA, S. H. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb02091.x · Cited by 509
Adaptive design methods in clinical trials–a review
Chow, S.-C., & Chang, M. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-11 · Cited by 482
Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom
J.P. (1971) · Toxicon · doi:10.1016/0041-0101(71)90098-5 · Cited by 480
Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin
Maraganore, J. M., Bourdon, P., Jablonski, J., Ramachandran, K. L., & Fenton, J. W. (1990) · Biochemistry · doi:10.1021/bi00482a021 · Cited by 466
Nauck, M. A., Duran, S., Kim, D., Johns, D., Northrup, J., Festa, A., Brodows, R., & Trautmann, M. (2007) · Diabetologia · doi:10.1007/s00125-006-0510-2 · Cited by 437
Conus Venom Peptide Pharmacology
Lewis, R. J., Dutertre, S., Vetter, I., & Christie, M. J. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005322 · Cited by 424
Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci
Veiseh, M., Gabikian, P., Bahrami, S.-B., Veiseh, O., Zhang, M., Hackman, R. C., Ravanpay, A. C., Stroud, M. R., Kusuma, Y., Hansen, S. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3948 · Cited by 422
Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice
Bonifazi, F., Jutel, M., Biló, B. M., Birnbaum, J., Muller, U., & the EAACI Interest Group on Insect Venom Hypersensitivity (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00960.x · Cited by 420
DeBin, J. A., Maggio, J. E., & Strichartz, G. R. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.2.c361 · Cited by 407
Black mamba venom peptides target acid-sensing ion channels to abolish pain
Diochot, S., Baron, A., Salinas, M., Douguet, D., Scarzello, S., Dabert-Gay, A.-S., Debayle, D., Friend, V., Alloui, A., Lazdunski, M., et al. (2012) · Nature · doi:10.1038/nature11494 · Cited by 402
Scarborough, R. M., Naughton, M. A., Teng, W., Rose, J. W., Phillips, D. R., Nannizzi, L., Arfsten, A., Campbell, A. M., & Charo, I. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54042-4 · Cited by 375
Moreno, M., & Giralt, E. (2015) · Toxins · doi:10.3390/toxins7041126 · Cited by 375
Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri
Scarborough, R. M., Rose, J. W., Hsu, M. A., Phillips, D. R., Fried, V. A., Campbell, A. M., Nannizzi, L., & Charo, I. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92826-7 · Cited by 371
Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus.
Gan, Z. R., Gould, R. J., Jacobs, J. W., Friedman, P. A., & Polokoff, M. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77710-2 · Cited by 368
Snake venom components and their applications in biomedicine
Koh, D. C. I., Armugam, A., & Jeyaseelan, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6315-0 · Cited by 362
Spotnitz, W. D. (2014) · ISRN Surgery · doi:10.1155/2014/203943 · Cited by 355
Scorpion venom components as potential candidates for drug development
Ortiz, E., Gurrola, G. B., Schwartz, E. F., & Possani, L. D. (2015) · Toxicon · doi:10.1016/j.toxicon.2014.11.233 · Cited by 335
Brogden, R. N., Todd, P. A., & Sorkin, E. M. (1988) · Drugs · doi:10.2165/00003495-198836050-00003 · Cited by 318
Bittl, J. A., Chaitman, B. R., Feit, F., Kimball, W., & Topol, E. J. (2001) · American Heart Journal · doi:10.1067/mhj.2001.119374 · Cited by 313
The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain
Clark, R. J., Jensen, J., Nevin, S. T., Callaghan, B. P., Adams, D. J., & Craik, D. J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000620 · Cited by 313
Ziconotide: a review of its pharmacology and use in the treatment of pain
McGivern, J. G. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2007.3.1.69 · Cited by 310
Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors
Hartman, G. D., Egbertson, M. S., Halczenko, W., Laswell, W. L., Duggan, M. E., Smith, R. L., Naylor, A. M., Manno, P. D., & Lynch, R. J. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00102a020 · Cited by 301
Snake venom proteins acting on hemostasis
Braud, S. (2000) · Biochimie · doi:10.1016/s0300-9084(00)01178-0 · Cited by 296
Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting
Cescato, R., Maina, T., Nock, B., Nikolopoulou, A., Charalambidis, D., Piccand, V., & Reubi, J. C. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045054 · Cited by 293
Meng, Z., Yang, P., Shen, Y., Bei, W., Zhang, Y., Ge, Y., Newman, R. A., Cohen, L., Liu, L., Thornton, B., et al. (2009) · Cancer · doi:10.1002/cncr.24602 · Cited by 289
Peptide therapeutics from venom: Current status and potential
Pennington, M. W., Czerwinski, A., & Norton, R. S. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.09.029 · Cited by 278
Lee, C. J., & Ansell, J. E. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03916.x · Cited by 272
A tarantula peptide against pain via ASIC1a channels and opioid mechanisms
Mazzuca, M., Heurteaux, C., Alloui, A., Diochot, S., Baron, A., Voilley, N., Blondeau, N., Escoubas, P., Gélot, A., Cupo, A., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1940 · Cited by 266
Cell-penetrating peptides transport therapeutics into cells
Ramsey, J. D., & Flynn, N. H. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.003 · Cited by 256
Lago, J., Rodríguez, L., Blanco, L., Vieites, J., & Cabado, A. (2015) · Marine Drugs · doi:10.3390/md13106384 · Cited by 244
DeYoung, M. B., MacConell, L., Sarin, V., Trautmann, M., & Herbert, P. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0050 · Cited by 241
Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor
Qi, F., Li, A., Inagaki, Y., Kokudo, N., Tamura, S., Nakata, M., & Tang, W. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.12.007 · Cited by 238
The long road of research on snake venom serine proteinases
Serrano, S. M. T. (2013) · Toxicon · doi:10.1016/j.toxicon.2012.09.003 · Cited by 236
Chassagnon, I. R., McCarthy, C. A., Chin, Y. K.-Y., Pineda, S. S., Keramidas, A., Mobli, M., Pham, V., De Silva, T. M., Lynch, J. W., Widdop, R. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614728114 · Cited by 231
From snake venom toxins to therapeutics – Cardiovascular examples
Koh, C. Y., & Kini, R. M. (2012) · Toxicon · doi:10.1016/j.toxicon.2011.03.017 · Cited by 228
Harvey, A. L. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.10.020 · Cited by 210
Why do we study animal toxins?
Zhang, Y. (2015) · PubMed · doi:10.13918/j.issn.2095-8137.2015.4.183 · Cited by 198
FERREIRA, S. H., GREENE, L. J., ALABASTER, V. A., BAKHLE, Y. S., & VANE, J. R. (1970) · Nature · doi:10.1038/225379a0 · Cited by 191
Greig, N. H., Holloway, H. W., De Ore, K. A., Jani, D., Wang, Y., Zhou, J., Garant, M. J., & Egan, J. M. (1999) · Diabetologia · doi:10.1007/s001250051111 · Cited by 189
Morita, T. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.02.021 · Cited by 185
Scott, D. A., Wright, C. E., & Angus, J. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02247-1 · Cited by 177
The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
Furman, B. L. (2012) · Toxicon · doi:10.1016/j.toxicon.2010.12.016 · Cited by 166
Bradykinin-potentiating peptides: Beyond captopril
de Camargo, A. C. M., Ianzer, D. A., Guerreiro, J. R., & Serrano, S. M. T. (2011) · Toxicon · doi:10.1016/j.toxicon.2011.07.013 · Cited by 162
Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain
Romero, H. K., Christensen, S. B., Di Cesare Mannelli, L., Gajewiak, J., Ramachandra, R., Elmslie, K. S., Vetter, D. E., Ghelardini, C., Iadonato, S. P., Mercado, J. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621433114 · Cited by 162
Zhang, L., & Falla, T. J. (2009) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2009.05.013 · Cited by 161
Drug Development: From Concept to Marketing!
Tamimi, N. A. M., & Ellis, P. (2009) · Nephron Clinical Practice · doi:10.1159/000232592 · Cited by 159
Ziconotide: a clinical update and pharmacologic review
Pope, J. E., & Deer, T. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.784269 · Cited by 159
Gomes, A., Teixeira, C. A. S., Ferraz, R., Prudêncio, C., & Gomes, P. A. C. (2017) · Molecules · doi:10.3390/molecules22101743 · Cited by 159
Molecular cloning and sequence analysis of cDNA for batroxobin, a thrombin-like snake venom enzyme.
Itoh, N., Tanaka, N., Mihashi, S., & Yamashina, I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61479-6 · Cited by 158
Cone Snails: A Big Store of Conotoxins for Novel Drug Discovery
Gao, B., Peng, C., Yang, J., Yi, Y., Zhang, J., & Shi, Q. (2017) · Toxins · doi:10.3390/toxins9120397 · Cited by 150
Action of C-type natriuretic peptide in isolated canine arteries and veins
Wei, C., Aarhus, L. L., Miller, V. M., & Burnett, J. C. J. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.264.1.h71 · Cited by 148
Biollaz, J., Burnier, M., Turini, G. A., Brunner, D. B., Porchet, M., Gomez, H. J., Jones, K., Ferber, F., Abrams, W. B., Gavras, H. P., et al. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.92 · Cited by 145
Kesavan, K. P., Ratliff, J., Johnson, E. W., Dahlberg, W. K., Asara, J. M., Misra, P., Frangioni, J. V., & Jacoby, D. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066092 · Cited by 144
Snake venom toxins: toxicity and medicinal applications
Chan, Y. S., Cheung, R. C. F., Xia, L., Wong, J. H., Ng, T. B., & Chan, W. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7610-9 · Cited by 144
Scarborough, R. M. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70075-x · Cited by 143
NaV1.7 as a pain target – From gene to pharmacology
Vetter, I., Deuis, J. R., Mueller, A., Israel, M. R., Starobova, H., Zhang, A. H., Rash, L. D., & Mobli, M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.015 · Cited by 141
Fu, S., Hirte, H. W., Welch, S. A., Ilenchuk, T. T., Lutes, T., Rice, C., Fields, N., Nemet, A., Dugourd, D., Piha-Paul, S. A., et al. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0438-z · Cited by 140
Engineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T Lymphocytes
Pennington, M. W., Beeton, C., Galea, C. A., Smith, B. J., Chi, V., Monaghan, K. P., Garcia, A., Rangaraju, S., Giuffrida, A., Plank, D. W., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.052704 · Cited by 138
Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke
Yang, M., Huo, X., Miao, Z., & Wang, Y. (2019) · Drugs · doi:10.1007/s40265-019-01078-0 · Cited by 137
Wigger, E., Kuhn‐Nentwig, L., & Nentwig, W. (2002) · Toxicon · doi:10.1016/s0041-0101(01)00277-x · Cited by 135
Fox, J. W., & Serrano, S. M. T. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782023739 · Cited by 135
Scorpion venoms as a potential source of novel cancer therapeutic compounds
Ding, J., Chua, P., Bay, B., & Gopalakrishnakone, P. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370213513991 · Cited by 134
Lorenz, M., Evers, A., & Wagner, M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.022 · Cited by 130
Effect of apamin, a toxin that inhibits Ca2+-dependent K+ channels, on learning and memory processes
Messier, C., Mourre, C., Bontempi, B., Sif, J., Lazdunski, M., & Destrade, C. (1991) · Brain Research · doi:10.1016/0006-8993(91)90950-z · Cited by 129
Butte, P. V., Mamelak, A. N., Parrish-Novak, J. E., Drazin, D. G., Shweikeh, F., Gangalum, P. R., Chesnokova, A., Ljubimova, J. Y., & Black, K. L. (2014) · Neurosurgical FOCUS · doi:10.3171/2013.11.focus13497 · Cited by 127
Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo
Jang, S. H., Choi, S. Y., Ryu, P. D., & Lee, S. Y. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.066 · Cited by 122
Qin, T., Zhao, X., Yun, J. H., Zhang, L.-X., Ruan, Z., & Pan, B.-R. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5210 · Cited by 121
In Vivo Detection of Human TRPV6-Rich Tumors with Anti-Cancer Peptides Derived from Soricidin
Bowen, C. V., DeBay, D. R., Ewart, H. S., Gallant, P., Gormley, S., Ilenchuk, T. T., Iqbal, U. H., Lutes, T., Martina, M., Mealing, G. A. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058866 · Cited by 119
Tarcha, E. J., Chi, V., Muñoz-Elías, E. J., Bailey, D., Londono, L. M., Upadhyay, S. K., Norton, K., Banks, A., Tjong, I., Nguyen, H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.191890 · Cited by 117
Hennerici, M. G., Kay, R., Bogousslavsky, J., Lenzi, G. L., Verstraete, M., & Orgogozo, J. M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69776-6 · Cited by 117
Patil, C. G., Walker, D., Miller, D. M., Butte, P. V., Morrison, B., Kittle, D. S., Hansen, S. J., Nufer, K. L., Byrnes-Blake, K. A., Yamada, M., et al. (2019) · Neurosurgery · doi:10.1093/neuros/nyz125 · Cited by 114
Assunção, J., Guedes, A. C., & Malcata, F. X. (2017) · Marine Drugs · doi:10.3390/md15120393 · Cited by 113
Tokunaga, F., Nagasawa, K., Tamura, S., Miyata, T., Iwanaga, S., & Kisiel, W. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77860-0 · Cited by 112
Merlin, M., Gecchele, E., Capaldi, S., Pezzotti, M., & Avesani, L. (2014) · BioMed Research International · doi:10.1155/2014/136419 · Cited by 112
Lee, C. Y. W., Chen, H. H., Lisý, O., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009336233 · Cited by 111
Exenatide: pharmacokinetics, clinical use, and future directions
Knop, F. K., Brønden, A., & Vilsbøll, T. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1282463 · Cited by 111
Valverde, P., Kawai, T., & Taubman, M. A. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301213 · Cited by 110
K+ channel types targeted by synthetic OSK1, a toxin fromOrthochirus scrobiculosusscorpion venom
Mouhat, S., Visan, V., Ananthakrishnan, S., et al. (2004) · Biochemical Journal · doi:10.1042/bj20041379 · Cited by 110
Snake Venom Activators of Factor X: An Overview
Tans, G., & Rosing, J. (2001) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000048067 · Cited by 108
Neuronal nicotinic receptors as analgesic targets: It's a winding road
Umana, I. C., Daniele, C. A., & McGehee, D. S. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.001 · Cited by 105
Administration strategies for proteins and peptides
Ibraheem, D., Elaïssari, A., & Fessi, H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.059 · Cited by 105
Minor snake venom proteins: Structure, function and potential applications
Boldrini-França, J., Cologna, C. T., Pucca, M. B., Bordon, K. D. C. F., Amorim, F. G., Anjolette, F. A. P., Cordeiro, F. A., Wiezel, G. A., Cerni, F. A., Pinheiro-Júnior, E. L., et al. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.12.022 · Cited by 104
Self-citationde Souza, A. H., Ferreira, J., Cordeiro, M. N., Vieira, L. B., de Castro, C. J., Trevisan, G., Reis, H. J., Souza, I. A., Richardson, M., Prado, M. A. M., et al. (2008) · Pain · doi:10.1016/j.pain.2008.07.014 · Cited by 103
Ferreira, S. H., & Silva, M. R. E. (1965) · Cellular and Molecular Life Sciences · doi:10.1007/bf02144709 · Cited by 103
Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy
Schechter, M., Andrade, B. B., He, T., Richter, G. H., Tosh, K. W., Policicchio, B. B., Singh, A., Raehtz, K. D., Sheikh, V., Ma, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam5441 · Cited by 103
Gupta, S. D., Debnath, A., Saha, A., Giri, B., Tripathi, G., Vedasiromoni, J. R., Gomes, A., & Gomes, A. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.06.004 · Cited by 101
A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain
King, J. V. L., Emrick, J. J., Kelly, M. J. S., Herzig, V., King, G. F., Medzihradszky, K. F., & Julius, D. J. (2019) · Cell · doi:10.1016/j.cell.2019.07.014 · Cited by 98
Evolution of Exenatide as a Diabetes Therapeutic
Bhavsar, S., Mudaliar, S. R. D., & Cherrington, A. D. (2013) · Current Diabetes Reviews · doi:10.2174/1573399811309020007 · Cited by 96
Miao, Q., Bi, L., Li, X., Miao, S., Zhang, J., Zhang, S., Yang, Q., Xie, Y., Zhang, J., & Wang, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011370 · Cited by 95
Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain
Smith, H. H. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s4438 · Cited by 93
Chlorotoxin: Structure, activity, and potential uses in cancer therapy
Ojeda, P. G., Wang, C. K. L., & Craik, D. J. (2015) · Biopolymers · doi:10.1002/bip.22748 · Cited by 93
Epibatidine: A Promising Natural Alkaloid in Health
Salehi, B., Sestito, S., Rapposelli, S., Peron, G., Calina, D., Sharifi-Rad, M., Sharopov, F., Martins, N., & Sharifi-Rad, J. (2018) · Biomolecules · doi:10.3390/biom9010006 · Cited by 91
Bee venom acupuncture for rheumatoid arthritis: a systematic review of randomised clinical trials
Lee, J. A., Son, M. J., Choi, J., Jun, J. H., Kim, J., & Lee, M. S. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006140 · Cited by 91
Trifirò, G., Gini, R., Barone‐Adesi, F., Beghi, E., Cantarutti, A., Capuano, A., Carnovale, C., Clavenna, A., Dellagiovanna, M., Ferrajolo, C., et al. (2018) · Drug Safety · doi:10.1007/s40264-018-0732-5 · Cited by 91
Imaging glioma extent with 131I-TM-601.
Hockaday, D. C., Shen, S., Fiveash, J. B., Raubitschek, A. A., Colcher, D. M., Liu, A., Alvarez, V. L., & Mamelak, A. N. (2005) · PubMed · Cited by 90
Recommendations for the Use of Leeches in Reconstructive Plastic Surgery
Mumcuoğlu, K. Y. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/205929 · Cited by 89
Holleman, W. H., & Weiss, L. J. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33700-6 · Cited by 88
Brust, A., Palant, E., Croker, D. E., Colless, B., Drinkwater, R. D., Patterson, B., Schroeder, C. I., Wilson, D. T. R., Nielsen, C. K., Smith, M. T., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9003413 · Cited by 87
Heterologous fibrin sealant derived from snake venom: from bench to bedside – an overview
Ferreira, R. S., de Barros, L. C., Abbade, L. P. F., Barraviera, S. R. C. S., Silvares, M. R. C., de Pontes, L. G., dos Santos, L. D., & Barraviera, B. (2017) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1186/s40409-017-0109-8 · Cited by 87
Glioblastoma multiforme targeted therapy: The Chlorotoxin story
Cohen‐Inbar, O., & Zaaroor, M. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2016.04.012 · Cited by 86
Guanidinium Toxins and Their Interactions with Voltage-Gated Sodium Ion Channels
Durán-Riveroll, L. M., & Cembella, A. D. (2017) · Marine Drugs · doi:10.3390/md15100303 · Cited by 83
Henry, R. R., Rosenstock, J., Logan, D. K., Alessi, T. R., Luskey, K. L., & Baron, M. A. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.12.009 · Cited by 82
Novel Delivery Systems for Improving the Clinical Use of Peptides
Kovalainen, M., Mönkäre, J., Riikonen, J., Pesonen, U., Vlasova, M. A., Salonen, J., Lehto, V., Järvinen, K., & Herzig, K. (2015) · Pharmacological Reviews · doi:10.1124/pr.113.008367 · Cited by 82
de Azevedo, R. A., Figueiredo, C. R., Ferreira, A. K., Matsuo, A. L., Massaoka, M. H., Girola, N., Auada, A. V. V., Farias, C. F., Pasqualoto, K. F. M., Rodrigues, C. P., et al. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.024 · Cited by 81
Transduction of the Scorpion Toxin Maurocalcine into Cells
Estève, E., Mabrouk, K., Dupuis, A., Smida‐Rezgui, S., Altafaj, X., Grünwald, D., Platel, J., Andreotti, N., Marty, I., Sabatier, J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412521200 · Cited by 81
Burkhart, W., Smith, G. F. H., Su, J., Parikh, I., & LeVine, H. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80559-y · Cited by 80
Friends or Foes? Emerging Impacts of Biological Toxins
Clark, G. C., Casewell, N. R., Elliott, C. T., Harvey, A. L., Jamieson, A. G., Strong, P. N., & Turner, A. D. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.12.004 · Cited by 80
Mechanism of ancrod anticoagulation
Pizzo, S. V., Schwartz, M. L., Hill, R. L., & McKee, P. A. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107107 · Cited by 78
Favaloro, E. J., & Wong, R. C. W. (2014) · Pathology · doi:10.1097/pat.0000000000000142 · Cited by 78
Functional improvement of hemostatic dressing by addition of recombinant batroxobin
Seon, G. M., Lee, M. H., Kwon, B., Kim, M. S., Koo, M.-A., Kim, D., Seomun, Y., Kim, J.-T., & Park, J. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.10.024 · Cited by 77
Tanner, M. R., Tajhya, R. B., Huq, R., Gehrmann, E. J., Rodarte, K. E., Atik, M., Norton, R. S., Pennington, M. W., & Beeton, C. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.03.014 · Cited by 77
Tornesello, A. L., Buonaguro, L., Tornesello, M. L., & Buonaguro, F. M. (2017) · Molecules · doi:10.3390/molecules22081282 · Cited by 76
Vink, S., & Alewood, P. F. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02082.x · Cited by 74
Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.
Christensen, M., Knop, F. K., Holst, J. J., & Vilsbøll, T. (2009) · PubMed · Cited by 74
Vu, T. T., Stafford, A. R., Leslie, B. A., Kim, P. Y., Fredenburgh, J. C., & Weitz, J. I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.464750 · Cited by 73
Gutierrez, V. P., Konno, K., Chacur, M., Sampaio, S. C., Picolo, G., Brigatte, P., Zambelli, V. O., & Cury, Y. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.053 · Cited by 72
Tx2-6 toxin of the Phoneutria nigriventer spider potentiates rat erectile function
Nunes, K. P., Gonçalves, A. C. D. C., Lanza, L. F., Côrtes, S. F., Cordeiro, M. N., Richardson, M., Pimenta, A. M. C., Webb, R. C., Leite, R. B., & de Lima, M. E. (2008) · Toxicon · doi:10.1016/j.toxicon.2008.02.010 · Cited by 71
Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain
Grishin, E. V., Savchenko, G. A., Vassilevski, A. A., Korolkova, Y. V., Boychuk, Y. A., Viatchenko‐Karpinski, V., Nadezhdin, K. D., Arseniev, A. S., Pluzhnikov, K. A., Kulyk, V. B., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21949 · Cited by 71
Leech therapeutic applications.
Abdualkader, A. M., Ghawi, A. M., Alaama, M., et al. (2013) · PubMed · Cited by 71
Computational Studies of Snake Venom Toxins
Ojeda, P. G., Ramírez, D., Alzate‐Morales, J. H., Caballero, J., Kaas, Q., & González, W. (2017) · Toxins · doi:10.3390/toxins10010008 · Cited by 68
Brinkhous, K. M., Read, M. S., Fricke, W., & Wagner, R. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1463 · Cited by 64
Tabacova, S. A., & Kimmel, C. A. (2001) · Reproductive Toxicology · doi:10.1016/s0890-6238(01)00161-7 · Cited by 63
Kolosov, A., Goodchild, C. S., & Cooke, I. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00741.x · Cited by 63
Wilson, D. T. R., & Daly, N. L. (2018) · Microarrays · doi:10.3390/ht7030019 · Cited by 63
Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa
Tcheng, J. E., & O’Shea, J. C. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.8.1199 · Cited by 62
Buchaim, D. V., Cassaro, C. V., Shindo, J. V. T. C., Coletta, B. B. D., Pomini, K. T., Rosso, M. P. D. O., Campos, L. M. G., Ferreira, R. S., Barraviera, B., & Buchaim, R. L. (2019) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/1678-9199-jvatitd-2019-0038 · Cited by 60
Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial
Hartmann, A., Muellner, J., Meier, N., Hesekamp, H., van Meerbeeck, P., Habert, M., Kas, A., Tanguy, M., Mazmanian, M., Hervé, O., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158235 · Cited by 59
Toxins Targeting the KV1.3 Channel: Potential Immunomodulators for Autoimmune Diseases
Zhao, Y., Huang, J., Yuan, X., Peng, B., Liu, W., Han, S. H., & He, X. (2015) · Toxins · doi:10.3390/toxins7051749 · Cited by 58
Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis
Bitencourt, C. S., Pereira, P. A. T., Ramos, S. G., Sampaio, S. V., Arantes, E. C., Aronoff, D. M., & Faccioli, L. H. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-3 · Cited by 58
Self-citationDesmoteplase: discovery, insights and opportunities for ischaemic stroke
Medcalf, R. L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01514.x · Cited by 54
Effects of apamin on memory processing of hippocampal-lesioned mice
Ikonen, S., & Riekkinen, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00616-0 · Cited by 54
Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide.
Jacoby, D. B., Dyskin, E., Yalçın, M., Kesavan, K. P., Dahlberg, W. K., Ratliff, J., Johnson, E. W., & Mousa, S. A. (2010) · PubMed · Cited by 54
Boldrini-França, J., Pinheiro-Júnior, E. L., Peigneur, S., Pucca, M. B., Cerni, F. A., Borges, R. J., Costa, T. R., Carone, S. E. I., Fontes, M. R. M., Sampaio, S. V., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61258-x · Cited by 53
Self-citationThe beneficial effects of honeybee-venom serum on facial wrinkles in humans
Han, S. M., Hong, I. P., Woo, S. O., Chun, S. N., Park, K. K., Nicholls, Y. M., & Pak, S. C. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s84940 · Cited by 50
Ichiki, T., Dzhoyashvili, N. A., & Burnett, J. C. J. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.002 · Cited by 50
Traynor, J. R. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.1.69 · Cited by 49
Xie, X.-B., Yin, J.-Q., Wen, L.-L., Gao, Z.-H., Zou, C.-Y., Wang, J., Huang, G., Tang, Q.-L., Colombo, C., He, W.-L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047375 · Cited by 47
Xie, X., Huang, X., Li, J., Lv, X., Huang, J., Tang, S., & Sun, Y. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.04.038 · Cited by 46
Involvement of Acid-Sensing Ion Channel 1b in the Development of Acid-Induced Chronic Muscle Pain
Chang, C.-T., Fong, S. W., Lee, C., Chuang, Y.-C., Lin, S.-H., & Chen, C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01247 · Cited by 45
Reis, C. V., de Andrade, S. A., Ramos, O. H. P., Ramos, C. R. R., Ho, P. L., Batista, I. D. F. C., & Chudzinski‐Tavassi, A. M. (2006) · Biochemical Journal · doi:10.1042/bj20060325 · Cited by 43
da Silva, C. N., Nunes, K. P., Torres, F. S., Cassoli, J. S., dos Santos, D. M., Almeida, F. D. M., Matavel, A., Cruz, J. S., Santos‐Miranda, A., Nunes, A., et al. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.06.081 · Cited by 42
Manda, P., Kushwaha, A. S., Kundu, S., Shivakumar, H. N., Jo, S. B., & Murthy, S. N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.044 · Cited by 41
Reid, P. F. (2007) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v27.i4.10 · Cited by 40
Through the looking glass – a new world of proteins enabled by chemical synthesis
Kent, S. B. H., Sohma, Y., Liu, S., Bang, D., Pentelute, B. L., & Mandal, K. (2012) · Journal of Peptide Science · doi:10.1002/psc.2421 · Cited by 40
The Mechanisms of Chansu in Inducing Efficient Apoptosis in Colon Cancer Cells
Li, C., Hashimi, S. M., Cao, S., Mellick, A. S., Duan, W., Good, D. M., & Wei, M. Q. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/849054 · Cited by 40
Jones, S., & Howl, J. (2011) · Bioconjugate Chemistry · doi:10.1021/bc2002924 · Cited by 39
Wysham, C., Rosenstock, J., Vetter, M. L., Dong, F., Öhman, P., & Iqbal, N. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13056 · Cited by 38
The Role of Toxins in the Pursuit for Novel Analgesics
Maatuf, Y., Geron, M., & Priel, A. (2019) · Toxins · doi:10.3390/toxins11020131 · Cited by 38
Characterization of IRDye 800CW chlorotoxin as a targeting agent for brain tumors
Kovar, J. L., Curtis, E. T., Othman, S. F., Simpson, M. A., & Olive, D. M. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.05.013 · Cited by 37
Lixisenatide: First Global Approval
Elkinson, S., & Keating, G. M. (2013) · Drugs · doi:10.1007/s40265-013-0033-3 · Cited by 37
Nicoletti, N. F., Erig, T. C., Zanin, R. F., Roxo, M. R. R., Ferreira, N. P., Gomez, M. V., Morrone, F. B., & Campos, M. M. (2017) · Toxicon · doi:10.1016/j.toxicon.2017.02.001 · Cited by 36
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders
Duskey, J. T., Belletti, D., Pederzoli, F., Vandelli, M. A., Forni, F., Ruozi, B., & Tosi, G. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.08.006 · Cited by 35
Update of Peptides with Antibacterial Activity
Vila‐Farrés, X., Giralt, E., & Vilà, J. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712804485818 · Cited by 34
Huang, J., Han, S. H., Sun, Q., Zhao, Y., Liu, J., Yuan, X., Mao, W., Peng, B., Liu, W., Yin, J., et al. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0158-2 · Cited by 34
Veytia‐Bucheli, J. I., Jiménez-Vargas, J. M., Melchy-Pérez, E., Sandoval-Hernández, M. A., Possani, L. D., & Rosenstein, Y. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0257-7 · Cited by 34
Scorpion toxins targeting Kv1.3 channels: insights into immunosuppression
de Oliveira, I. S., Ferreira, I. G., Alexandre-Silva, G. M., Cerni, F. A., Cremonez, C. M., Arantes, E. C., Zottich, U., & Pucca, M. B. (2019) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/1678-9199-jvatitd-1481-18 · Cited by 34
Self-citationFerrajolo, C., Coloma, P. M., Verhamme, K. M. C., Schuemie, M. J., de Bie, S., Gini, R., Herings, R. M. C., Mazzaglia, G., Picelli, G., Giaquinto, C., et al. (2014) · Drug Safety · doi:10.1007/s40264-013-0132-9 · Cited by 33
Liu, S., Marder, V. J., Levy, D. E., Wang, S., Yang, F., Paganini‐Hill, A., & Fisher, M. (2011) · Stroke · doi:10.1161/strokeaha.111.622753 · Cited by 33
Singh, K., Davies, G., Alenazi, Y., Eaton, J. R. O., Kawamura, A., & Bhattacharya, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-04378-1 · Cited by 33
Wei, J.-M., Zhu, M., Zhang, Z., Zhen-geng, J. I. A., He, X., Wan, Y., Wang, S., Dian-rong, X. I. U., Tang, Y., Jie, L. I., et al. (2010) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2010.05.016 · Cited by 32
Modern trends in animal venom research - omics and nanomaterials
Utkin, Y. N. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i1.4 · Cited by 31
Neurobiology and therapeutic applications of neurotoxins targeting transmitter release
Ovsepian, S. V., O’Leary, V. B., Ayvazyan, N. M., Al-Sabi, A., Ntziachristos, V., & Dolly, J. O. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.016 · Cited by 31
Oliveira-Mendes, B. B. R., Horta, C. C. R., do Carmo, A. O., Biscoto, G. L., Sales-Medina, D. F., Leal, H. G., Brandão‐Dias, P. F. P., Miranda, S. E. M., Aguiar, C. J., Cardoso, V. N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33133-3 · Cited by 30
In vitro assessment of cytotoxic activities of Lachesis muta muta snake venom
Stransky, S., Costal-Oliveira, F., Lopes-de-Souza, L., Guerra-Duarte, C., Chávez-Olórtegui, C., & Braga, V. M. M. (2018) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006427 · Cited by 29
Badr, G., Sayed, D. M., Maximous, D., Mohamed, A. O., & Gül, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366366 · Cited by 28
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis
Lang, S., Manning, N., Armstrong, N., Misso, K., Allen, A., Nisio, M. D., & Kleijnen, J. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.657299 · Cited by 28
Dual actions of Psalmotoxin at ASIC1a and ASIC2a heteromeric channels (ASIC1a/2a)
Liu, Y., Hagan, R., & Schoellerman, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25386-9 · Cited by 27
The use of natural ingredients in innovative Korean cosmeceuticals
Juhász, M. L. W., Levin, M. K., & Marmur, E. S. (2018) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.12492 · Cited by 26
Co-Localization of Crotamine with Internal Membranes and Accentuated Accumulation in Tumor Cells
Mambelli-Lisboa, N. C., Sciani, J. M., da Silva, Á. R. D. B. P., & Kerkis, I. (2018) · Molecules · doi:10.3390/molecules23040968 · Cited by 24
Ximelagatran: An orally active direct thrombin inhibitor
Gulseth, M. P. (2005) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp040534 · Cited by 23
Pucca, M. B., Bertolini, T. B., Cerni, F. A., Bordon, K. D. C. F., Peigneur, S., Tytgat, J., Bonato, V. L. D., & Arantes, E. C. (2015) · Immunology · doi:10.1111/imm.12559 · Cited by 23
Self-citationShibao, P. Y. T., Cologna, C. T., Filho, R. M., Wiezel, G. A., Fujimura, P. T., Ueira‐Vieira, C., & Arantes, E. C. (2018) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1186/s40409-018-0173-8 · Cited by 23
Self-citationBrigatte, P., Konno, K., Gutierrez, V. P., Sampaio, S. C., Zambelli, V. O., Picolo, G., Curi, R., & Cury, Y. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.04.012 · Cited by 21
Trujillo, J. M., & Goldman, J. D. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1962 · Cited by 21
Freitas, D. D. S., Boldrini-França, J., & Arantes, E. C. (2015) · Protein and Peptide Letters · doi:10.2174/0929866522666151013130742 · Cited by 19
Self-citationEfficacy and safety of desmoteplase in acute ischemic stroke patients
Li, X., Li, L., Li, C., & Ma, Q. (2017) · Medicine · doi:10.1097/md.0000000000006667 · Cited by 19
Targets and Therapeutic Properties
Beeton, C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00064-6 · Cited by 16
A potential strategy for high-grade gliomas: combination treatment with lithium chloride and BmK CT
Fu, Y., Zheng, S., Huang, R., An, N., Zheng, Y., Zhang, Z., & Liang, A. (2011) · Biotechnology Letters · doi:10.1007/s10529-011-0741-2 · Cited by 15
Liu, Y., Li-ying, B., SU, X., Gao, S., LIU, J.-W., & Cui, X. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3552 · Cited by 13
Alves, P. L., Abdalla, F. M. F., Alponti, R. F., & Silveira, P. F. (2017) · Toxicon · doi:10.1016/j.toxicon.2017.06.001 · Cited by 12
Sato, A. C., Bösch, R. V., Will, S., Flores, M. P. A., Goldfeder, M. B., Pasqualoto, K. F. M., da Silva, B. A. V. G., de Andrade, S. A., & Chudzinski‐Tavassi, A. M. (2016) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1186/s40409-016-0093-4 · Cited by 11
Francischetti, I. M. B., & Gil, M. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813726-0.00164-1 · Cited by 10
Odegard, P. S., & DeSantis, A. J. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s4444 · Cited by 3
Cited by
The chemistry of snake venom and its medicinal potential
Oliveira, A. L., Viegas, M. F., da Silva, S. L., Soares, A. M., Ramos, M. J., & Fernandes, P. A. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00393-7 · Cited by 289
Zhang, Z., Li, Q., Li, H., Wei, S., Yu, W., Peng, Z., Wei, F., & Zhou, W. (2024) · BMC Genomics · doi:10.1186/s12864-024-11149-6 · Cited by 6
Structural modeling of peptide toxin–ion channel interactions using RosettaDock
Mateos, D. L., & Yarov‐Yarovoy, V. (2023) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26474 · Cited by 4
Metadata
- Authors
- Bordon, K. D. C. F., Cologna, C. T., Fornari-Baldo, E. C., Pinheiro-Júnior, E. L., Cerni, F. A., Amorim, F. G., Anjolette, F. A. P., Cordeiro, F. A., Wiezel, G. A., Cardoso, I. A., Ferreira, I. G., Oliveira, I. S. D., Boldrini-França, J., Pucca, M. B., Baldo, M. A., & Arantes, E. C.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2020-07-24
- Volume
- 11
- Pages
- 1132-1132
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3045196858
- Cited by
- 303
- References
- 192
- FWCI
- 19.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.